drug study of myo with right oopho 03

8/7/2019 DRUG STUDY of Myo With Right Oopho 03

1/44


2/44

Bisacodyl (Dulcolax)

Metoclopramide (Plasil)

Nalbuphine (Nubain)

Mefenamic Acid (Dolfenal)

Cefazolin (Fonvicol)

Ranitidine (Zantac)


3/44


4/44

Constipation.

Preparation for barium enema.

Pre and post operative.


5/44

Increases peristalsis and motor activity of

the small intestines by acting directly on

the smooth muscles. May stimulate the colonic intramural

plexus, and promote fluid accumulationin the intestines and colon.


6/44

stomach ache,

cramping weakness

sweating,

irritation of the rectal

area, diarrhea

dizziness

Occasionalabdominaldiscomfort,

Soreness in the analregion.


7/44

Nausea

vomiting, or other symptoms of

appendicitis;

Acute surgical abdomen

fecal impaction intestinal obstruction.


8/44

Monitor frequency and character ofstools.

Monitor occurrence of adverse reactions(abdominal cramps, nausea, vomiting,fluid and electrolyte imbalanced, muscleweakness).

Assess abdominal pain, nausea and

vomiting.

Teach the patient about dietary sourcesof fiber (bran, cereals, fruits andvegetable)

Discuss with the patient adequate fluid,bulk consumption and exercise facilitiesbowel movement.

Warn the patient of the excessive use ofdrug


9/44

References:

PPds Nursing Drug guide 2nd edition for

nursing students and professional nursespublished for MALAN PRESS INC. p.476

PPD 13th annual edition 2006-2007 p.294


10/44

Classification

CNS Drug CNS Drug

Dosage

(1 ampule)10mg/2ml

(1 ampule)10mg/2ml

Timing

Every 6hours 0000,0600, 1200,

1800

(IV Push)

Every 6hours 0000,0600, 1200,

1800

(IV Push)


11/44

To control post operative vomiting.


12/44

Dopamine antagonist that acts byincreasing receptor sensitivity and responseof upper GIT tissues to acetylcholine.

This causes contraction of gastric smoothmuscle, relaxation of the pyloric sphincterand duodenal bulb.

Increased peristalsis without gastric, biliaryand pancreatic secretions.

It also produces sedation and induces therelease of prolactin.


13/44

Restlessness

Drowsiness

Fatigue

Insomnia

Headache

Dizziness Nausea

Bowel Disturbance

Somnolence

Nervousness

dystonic reactions.

Increased pituitaryprolactin release

and menstrualdischarge.


14/44

Phaeochromocytoma.

Patients in who increased GI motility mightbe dangerous e.g. presence of GIhemorrhage mechanical obstruction orperforation.

Hypersensitivity or intolerance to drug.

Lactation.


15/44

Assess patients GI complaints: nausea,vomiting, anorexia, constipation,abdominal distention before and afteradministration.

Frequent monitor blood pressure ofpatients taking IV form of drug.

Monitor for possible drug inducedadverse reactions.

Assess mental status during treatment:depression, anxiety and irritability.

Assess patients and familys knowledge

of drug therapy


16/44

References::


nursing students and professional nursespublished for MALAN PRESS INC. p.490

PPD 13th

annual edition 2006-2007 p. 296


17/44

Classification

CNS Drug CNS Drug

Dosage

(1 ampule) (1 ampule)

Timing

Every 6hours 0000,0600, 1200,

1800

(IV Push)

Every 6hours 0000,0600, 1200,

1800

(IV Push)


18/44

Relief of moderate pain; for pre-

operatively analgesia.

Supplement to balanced anesthesia.

Obstetrical analgesia


19/44

Binds with opiate receptors in the CNS:

ascending pain pathways in limbic

system, thalamus, midbrain,hypothalamus, altering perception of

and emotional response to pain.

And it relieves pain


20/44

Sedation

Drowsiness

Sweating

Dryness of mouth

Nausea and

Vomiting Headac

Allergic reactions likerashes.


21/44

Hypersensitivity.


22/44

Assess patients and Familys knowledge

of drug therapy. Asses pain characteristics (location,

intensity, type) before administration andafter treatment,

Monitor vital signs after parenteral route..

Monitor respiratory depression; assessrespiratory rate, character and rhythm.Report respiratory if


23/44

References::

PPds Nursing Drug guide 2nd edition fornursing students and professional nursespublished for MALAN PRESS INC. p.27

PPD 13th



24/44

Classification

NSAIDs NSAIDs

Dosage

500mg/tab(1 Tablet)

500mg/tab(1 Tablet)

Timing

Every 6hours 0000,0600, 1200,

1800

(IV Push)

Every 6hours 0000,0600, 1200,

1800

(IV Push)


25/44

Relief of pain including post-operative

and headache and fever


26/44

Aspirin-like drug that has analgesic,antipyretic and anti-inflammatory, activities.

These activities appear to be due to itsability to inhibit cyclooxygenase and alsoantagonize certain effects of

prostaglandins.

It displays central and peripheral activities.


27/44

GI disturbances

GI hemorrhage

Drowsiness

Dizziness

Headache

Visual Disturbances

Visual disturbances

asthma

urticaria


28/44

Pregnancy and lactation.

Hypersensitivity.

If diarrhea and skin rash appears, the

drug should stop at once.

History of kidney or liver disease.


29/44

Advice the patient not to over dose the

drug.

Advice the patient to immediately reportpersistence or failure to relieve pain.

Do health teachings about the adversereaction of drug.

Instruct the patient to report the druginduced adverse reactions.


30/44

References::

PPds Nursing Drug guide 2nd edition fornursing students and professional nursespublished for MALAN PRESS INC. p.27

PPD 13th



31/44

Classification

Anti-infectives Anti-

infectives

Dosage

1g/10ml 1g/10ml

Timing

20 hoursprior to

procedure

(IV Push)

20 hoursprior to

procedure

(IV Push)


32/44

Post operative wound and trauma.

Gynecological infections.


33/44

Inhibits bacterial cell wall synthesis thus

promoting osmotic instability which

eventually leads to bacterial cell death.


34/44

Signs of allergy: skinrash and fever.

Nausea and

Vomiting.

Diarrhea

Oral thrush

Shock

Vitamin B groupdeficiencies.


35/44

Allergy to penicillin and cephalosporin.


36/44

Asses patients previous sensitivityreaction to penicillin and cephalosporin

Assess patient for signs and symptoms ofinfection before and during infection:fever, ear ache, characteristics ofwounds, sputum, urine, stool, and WBCcount.

Assess for anaphylactic reaction.

Renal function and possible superinfection.


37/44

References::


nursing students and professional nurses

published for MALAN PRESS INC. p. 494 PPD 13th annual edition 2006-2007 p. 291


38/44

Classification

Gastrointestinal

Drugs

Gastrointestinal

Drugs

Dosage

500 mg(while on drip)

500 mg(while on drip)

Timing

Every 12 hours0000, 1200

(IV Push)

Every 12 hours0000, 1200

(IV Push)


39/44

Prophylaxis of GI hemorrhage from stress

ulceration.


40/44

Inhibits histamine at H2 receptor site in

the gastric parietal cells, which inhibitsgastric acid secretion.


41/44

Nausea andVomiting

Abdominaldiscomforts

Headache

Fatigue

Dizziness

Diarrhea

Bradychardia

Depression

Insomnia

Alopecia


42/44

Hypersensitivity.


43/44

Used caution in presence of renal orhepatic impairment.

Assess potential for interactions with otherpharmacological agents patients maybetaking (E.G., increase or decrease effects

of toxicity).

Evaluate results of laboratory testtherapeutic effect and adverse reactions.

Assess knowledge/ teach patientappropriate use, possible sideeffects/appropriate interventions, and

adverse symptoms to report.


44/44

References::

PPDs Nursing Drug guide 2nd edition fornursing students and professional nursespublished for MALAN PRESS INC. p. 494

PPD 13th


drug study of myo with right oopho 03

Documents